Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7301
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)
Author: Bhaumik, M.
Muller, V.
Rozaklis, T.
Johnson, L.
Dobrenis, K.
Bhattacharyya, R.
Wurzelmann, S.
Finamore, P.
Hopwood, J.
Walkley, S.
Stanley, P.
Citation: Glycobiology, 1999; 9(12):1389-1396
Publisher: Oxford University Press
Issue Date: 1999
ISSN: 0959-6658
1460-2423
Statement of
Responsibility: 
Mantu Bhaumik, Vivienne J.Muller, Tina Rozaklis, Linda Johnson, Kostantin Dobrenis, Riddhi Bhattacharyya, Sarah Wurzelmann, Peter Finamore, John J.Hopwood, Steven U.Walkleya, and Pamela Stanley
Abstract: Mucopolysaccharidosis type III A (MPS III A, Sanfilippo syndrome) is a rare, autosomal recessive, lysosomal storage disease characterized by accumulation of heparan sulfate secondary to defective function of the lysosomal enzyme heparan N- sulfatase (sulfamidase). Here we describe a spontaneous mouse mutant that replicates many of the features found in MPS III A in children. Brain sections revealed neurons with distended lysosomes filled with membranous and floccular materials with some having a classical zebra body morphology. Storage materials were also present in lysosomes of cells of many other tissues, and these often stained positively with periodic-acid Schiff reagent. Affected mice usually died at 7-10 months of age exhibiting a distended bladder and hepatosplenomegaly. Heparan sulfate isolated from urine and brain had nonreducing end glucosamine- N -sulfate residues that were digested with recombinant human sulfamidase. Enzyme assays of liver and brain extracts revealed a dramatic reduction in sulfamidase activity. Other lysosomal hydrolases that degrade heparan sulfate or other glycans and glycosaminoglycans were either normal, or were somewhat increased in specific activity. The MPS III A mouse provides an excellent model for evaluating pathogenic mechanisms of disease and for testing treatment strategies, including enzyme or cell replacement and gene therapy.
Keywords: MPS III A
mouse
pathogenesis
Sanfilippo syndrome
Description: Copyright © 1999 Oxford University Press
DOI: 10.1093/glycob/9.12.1389
Published version: http://glycob.oxfordjournals.org/cgi/content/abstract/9/12/1389
Appears in Collections:Aurora harvest 5
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.